article · Nano-Structures & Nano-Objects
The continual increase in the anthropogenic discharge of pharmaceutical contaminants into the aquatic ecosystem is a cause for concern. This necessitated the study, which focuses on developing and evaluating bimetallic biomass-based nanocomposites as photocatalysts for the degradation of tilmicosin (TLM), a veterinary antibiotic commonly found in wastewater, under UV light. The Al₂O₃-Fe₂O₃ nanocomposite was synthesized via a wet impregnation method with CaO derived from snail shells and characterized using UV-Vis, XRD, FTIR, SEM, and EDS. FTIR analysis of Al₂O₃-Fe₂O₃ nanocomposite showed a prominent peak at 617 cm⁻¹, attributed to the Al–O and Fe–O bonds. XRD results show a face-centered cubic structure with a calculated d-spacing of 6.75554 Å. The UV-Vis of the nanocomposite recorded a λ max value of 335 nm with a calculated optical band gap of 3.04 eV, using Tauc’s plot. The SEM images showed rectangular or cubic-shaped aggregates with an average crystallite size of 28.06 ± 5.19 nm. Optimum degradation efficiency values of 86.79 and 80.69 % were recorded at catalyst doses of 0.3 and 0.2 g, respectively. Kinetics of the degradation process follows a pseudo-first-order model, with reaction rate constant (k) of 0.0112 min⁻¹ and 0.010 min⁻¹ for 0.3 g and 0.2 g Al₂O₃-Fe₂O₃-CaO catalyst. This high efficiency, simple preparation, and sustainable approach make Al₂O₃-Fe₂O₃-CaO a cost-effective, environmentally friendly photocatalyst for the remediation of antibiotic-polluted wastewater.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.nanoso.2025.101537
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.